BLAINJECTIONINJECTABLEPriority Review
Approved
Mar 2024
Lifecycle
Growth
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
WINREVAIR (sotatercept-csrk) is a Merck biologic approved March 2024 for pulmonary arterial hypertension and a broad pipeline across hematologic malignancies, solid tumors, and chronic kidney disease. The mechanism of action and specific pharmacologic class are undisclosed in current labeling. This injectable biologic represents a multi-indication growth asset with significant clinical expansion potential.
Growth
Early-stage biologic in growth phase with moderate competitive pressure (30) signals opportunity for sales force expansion and market development roles in primary care and specialty settings.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
WINREVAIR is a growth-stage biologic with multi-indication potential offering career stability and advancement opportunity through label expansion cycles. Working on this asset provides exposure to both primary care (CKD, anemia) and specialty oncology (hematologic malignancies) commercial models within a Merck portfolio.
Brand ManagerField Sales Representative
Worked on WINREVAIR at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.